Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon

被引:80
作者
Brown, CR
Reiner, SL
机构
[1] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Comm Immunol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA
关键词
D O I
10.1128/IAI.67.7.3329-3333.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genetic resistance and susceptibility to experimental Lyme arthritis have been linked with the production of interleukin-4 (IL-4) or gamma interferon (IFN-gamma), respectively. To determine the absolute requirement for these cytokines in disease outcome, we compared arthritis development in wild-type, IL-4-deficient IL-4 degrees, and IFN-gamma-deficient (IFN-gamma degrees) mice. While susceptible C3H mice developed swelling of ankle joints during the second week of infection, this swelling was exacerbated in C3H IFN-gamma degrees mice. Their arthritis severity scores at day 21, however, were similar, Resolution of arthritis was also similar between C3H and C3H IFN-gamma degrees mice. Arthritis-resistant DBA mice did not develop ankle swelling during the experimental period. There were no differences in ankle swelling or arthritis severity scores between control DBA mice and DBA IL-4 degrees mice at any of the time points tested. While the presence of spirochetes in various tissues was similar among all strains at day 21, DBA IL-4 degrees mice had a higher presence of spirochetes in blood, heart, and spleen than the DBA, C3H, and C3H IFN-gamma degrees mice did at day 60, DBA IL-4 degrees mice also had impaired ability to produce Borrelia-specific antibody responses, especially immunoglobulin G1, Thus, while IFN-gamma and IL-4 are not absolutely required for arthritis susceptibility or resistance, the production of IL-4 does appear to play an important role in Borrelia-specific antibody production and spirochete clearance.
引用
收藏
页码:3329 / 3333
页数:5
相关论文
共 31 条
[1]   B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis [J].
Anguita, J ;
Roth, R ;
Samanta, S ;
Gee, RJ ;
Barthold, SW ;
Mamula, M ;
Fikrig, E .
INFECTION AND IMMUNITY, 1997, 65 (08) :3037-3041
[2]   LYME BORRELIOSIS IN GENETICALLY RESISTANT AND SUSCEPTIBLE MICE WITH SEVERE COMBINED IMMUNODEFICIENCY [J].
BARTHOLD, SW ;
SIDMAN, CL ;
SMITH, AL .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1992, 47 (05) :605-613
[3]  
Barthold SW, 1996, LAB INVEST, V74, P57
[4]   LYME BORRELIOSIS IN SELECTED STRAINS AND AGES OF LABORATORY MICE [J].
BARTHOLD, SW ;
BECK, DS ;
HANSEN, GM ;
TERWILLIGER, GA ;
MOODY, KD .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :133-138
[5]  
BARTHOLD SW, 1997, CLIN INFECT DIS, V25, pS9
[6]   Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection [J].
Brown, CR ;
Reiner, SL .
INFECTION AND IMMUNITY, 1998, 66 (11) :5208-5214
[7]   Clearance of Borrelia burgdorferi may not be required for resistance to experimental Lyme arthritis [J].
Brown, CR ;
Reiner, SL .
INFECTION AND IMMUNITY, 1998, 66 (05) :2065-2071
[8]   CYTOKINE-MEDIATED REGULATION OF CHRONIC INTESTINAL HELMINTH INFECTION [J].
ELSE, KJ ;
FINKELMAN, FD ;
MALISZEWSKI, CR ;
GRENCIS, RK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (01) :347-351
[9]  
Ferber IA, 1996, J IMMUNOL, V156, P5
[10]  
Fikrig E, 1997, J IMMUNOL, V159, P5682